Compare KR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KR | GEHC |
|---|---|---|
| Founded | 1883 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9B | 38.9B |
| IPO Year | N/A | N/A |
| Metric | KR | GEHC |
|---|---|---|
| Price | $63.12 | $81.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $72.54 | ★ $88.27 |
| AVG Volume (30 Days) | ★ 5.9M | 2.9M |
| Earning Date | 03-05-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.22% | 0.17% |
| EPS Growth | N/A | ★ 32.35 |
| EPS | 1.16 | ★ 4.83 |
| Revenue | ★ $147,225,000,000.00 | $20,246,000,000.00 |
| Revenue This Year | $3.78 | $6.33 |
| Revenue Next Year | $2.10 | $4.32 |
| P/E Ratio | $54.45 | ★ $16.92 |
| Revenue Growth | N/A | ★ 3.51 |
| 52 Week Low | $58.12 | $57.65 |
| 52 Week High | $74.90 | $94.80 |
| Indicator | KR | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 53.86 | 43.84 |
| Support Level | $60.97 | $84.59 |
| Resistance Level | $62.80 | $87.60 |
| Average True Range (ATR) | 1.41 | 2.20 |
| MACD | 0.29 | -0.55 |
| Stochastic Oscillator | 89.86 | 4.64 |
Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of more than 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).